$KMDA News

Kamada: Undervalued, Yet Execution Risks Keep It A Hold

Kamada Announces FDA Approval Of New In-House Rapid Fluorescent Focus Inhibition Test Laboratory

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript

Kamada Q1 2026 Earnings Call: Complete Transcript

Kamada Affirms FY2026 Sales Guidance of $200.000M-$205.000M vs $201.581M Est

Kamada Q1 EPS $0.07 Misses $0.12 Estimate, Sales $45.240M Miss $46.722M Estimate

Significant Move: Lilach Payorski Invests $80K In Kamada Stock Options

Eran Nir Sees Potential Growth And Acquires $178K In Kamada Stock Options

David Tsur Takes A Bullish Stance, Acquiring $113K Worth Of Kamada Stock Options

Ishay Davidi Expands Holdings With $113K Kamada Stock Options Acquisition

Chaime Orlev At Kamada Secures Company Stock Options: $417K Acquired

Nir Livneh Enhances Portfolio With Kamada Stock Options: $206K Acquired

Benjamin Dekel Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $41K

Leon Recanati Expands Holdings With $115K Kamada Stock Options Acquisition

Assaf Itshayek Sees Potential Growth And Acquires Kamada Stock Options Worth $41K

Hanni Neheman Backs Up Beliefs With A Notable $118K Acquisition In Kamada Stock Options

Karnit Goldwasser At Kamada Secures Company Stock Options: $115K Acquired

Amir London Takes A Bullish Stance, Acquiring $1.56M Worth Of Kamada Stock Options

Boris Gorelik Takes A Bullish Stance, Acquiring Kamada Stock Options Worth $-9K

Kamada Secures Israeli Tax Ruling On $0.25 Dividend, Allowing Reduced Withholding For Nasdaq Treaty Shareholders